Development of pouchitis following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis: A role for serological markers and microbial pattern recognition receptor genes

Journal of Crohn's and Colitis

Volumn 2, Issue 2, 2008, Pages 142-151

  Ferrante, Marc ^a   Declerck, Sarah ^a   Coopmans, Tamara ^a   De Hertogh, Gert ^a   Van Assche, Gert ^a   Penninckx, Freddy ^a   Rutgeerts, Paul ^a   Geboes, Karel ^a   D'Hoore, Andre ^a   Vermeire, Séverine ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Genetics; Pouch; Pouchitis; Predictor; Serology; Ulcerative colitis

Indexed keywords

BIOLOGICAL MARKER; CHITOBIOSIDE CARBOHYDRATE ANTIBODY; OUTER MEMBRANE PORIN ANTIBODY; PROTEIN ANTIBODY; TOLL LIKE RECEPTOR 1;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GENE; GENE FUNCTION; GENETIC ANALYSIS; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; MAJOR CLINICAL STUDY; MALE; MICROBIAL PATTERN RECOGNITION GENE; PHENOTYPE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS;

EID: 43449138790     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2007.10.003     Document Type: Article

References (41)

1. Langholz E., Munkholm P., Davidsen M., and Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 103 5 (1992) 1444-1451
2. Fazio V.W., Ziv Y., Church J.M., et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 222 2 (1995) 120-127
3. Fazio V.W., Tekkis P.P., Remzi F., et al. Quantification of risk for pouch failure after ileal pouch anal anastomosis surgery. Ann Surg 238 4 (2003) 605-614
4. Keighley M.R., Grobler S., and Bain I. An audit of restorative proctocolectomy. Gut 34 5 (1993) 680-684
5. Meagher A.P., Farouk R., Dozois R.R., Kelly K.A., and Pemberton J.H. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 85 6 (1998) 800-803
6. Damgaard B., Wettergren A., and Kirkegaard P. Social and sexual function following ileal pouch-anal anastomosis. Dis Colon Rectum 38 3 (1995) 286-289
7. MacLean A.R., Cohen Z., MacRae H.M., et al. Risk of small bowel obstruction after the ileal pouch-anal anastomosis. Ann Surg 235 2 (2002) 200-206
8. Waljee A., Waljee J., Morris A.M., and Higgins P.D. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut 55 11 (2006) 1575-1580
9. Ferrante M., Declerck S., De Hertogh G., et al. Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis (2007 Oct 31) [Published online]
10. Pemberton J.H., Kelly K.A., Beart Jr. R.W., Dozois R.R., Wolff B.G., and Ilstrup D.M. Ileal pouch-anal anastomosis for chronic ulcerative colitis. Long-term results. Ann Surg 206 4 (1987) 504-513
11. Mahadevan U., and Sandborn W.J. Diagnosis and management of pouchitis. Gastroenterology 124 6 (2003) 1636-1650
12. Sandborn W.J., and Pardi D.S. Clinical management of pouchitis. Gastroenterology 127 6 (2004) 1809-1814
13. Shen B., Fazio V.W., Remzi F.H., et al. Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis. Clin Gastroenterol Hepatol 4 1 (2006) 81-89
14. Stahlberg D., Gullberg K., Liljeqvist L., Hellers G., and Lofberg R. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum 39 9 (1996) 1012-1018
15. Penna C., Dozois R., Tremaine W., et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 38 2 (1996) 234-239
16. Kuisma J., Jarvinen H., Kahri A., and Farkkila M. Factors associated with disease activity of pouchitis after surgery for ulcerative colitis. Scand J Gastroenterol 39 6 (2004) 544-548
17. Achkar J.P., Al Haddad M., Lashner B., et al. Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol 3 1 (2005) 60-66
18. Schmidt C.M., Lazenby A.J., Hendrickson R.J., and Sitzmann J.V. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg 227 5 (1998) 654-662
19. Fleshner P., Ippoliti A., Dubinsky M., et al. A prospective multivariate analysis of clinical factors associated with pouchitis after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 5 8 (2007) 952-958
20. Carter M.J., Di Giovine F.S., Cox A., et al. The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. Gastroenterology 121 4 (2001) 805-811
21. Aisenberg J., Legnani P.E., Nilubol N., et al. Are PANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am J Gastroenterol 99 3 (2004) 432-441
22. Fleshner P.R., Vasiliauskas E.A., Kam L.Y., et al. High level perinuclear antineutrophil cytoplasmic antibody (PANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 49 5 (2001) 671-677
23. Heyvaert G., Penninckx F., Filez L., Aerts R., Kerremans R., and Rutgeerts P. Restorative proctocolectomy in elective and emergency cases of ulcerative colitis. Int J Colorectal Dis 9 2 (1994) 73-76
24. Brett P.M., Yasuda N., Yiannakou J.Y., et al. Genetic and immunological markers in pouchitis. Eur J Gastroenterol Hepatol 8 10 (1996) 951-955
25. Hugot J.P., Chamaillard M., Zouali H., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 6837 (31-5-2001) 599-603
26. Lammers K.M., Vergopoulos A., Babel N., et al. Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. Inflamm Bowel Dis 11 5 (2005) 447-454
27. Ferrante M., Henckaerts L., Joossens M., et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 56 10 (2007) 1394-1403
28. Moskowitz R.L., Shepherd N.A., and Nicholls R.J. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1 3 (1986) 167-174
29. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170 (1989) 2-6
30. Silverberg M.S., Satsangi J., Ahmad T., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19 Suppl A (2005) 5-36
31. Pierik M., Joossens S., Van Steen K., et al. Toll-like receptor-1,-2, and-6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 12 1 (2006) 1-8
32. Lammers K., Ouburg S., Crusius B., et al. Synergistic effect of Cd14 and Tlr9 polymorphisms in the susceptibility to develop chronic relapsing pouchitis. Gastroenterology 128 4 (2005) A444-A445
33. Fleshner P., Vasiliauskas E., Dubinsky M., et al. Both preoperative PANCA and CB1R1 flagellin expression in ulcerative colitis (UC) patients influence pouchitis development after ileal pouch-anal anastomosis (IPAA). Gastroenterology 130 4 (2006) A25
34. Dendrinos K.G., Becker J.M., Stucchi A.F., Saubermann L.J., Lamorte W., and Farraye F.A. Anti-saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis. J Gastrointest Surg 10 7 (2006) 1060-1064
35. Lohmuller J.L., Pemberton J.H., Dozois R.R., Ilstrup D., and van Heerden J. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 211 5 (1990) 622-627
36. Aisenberg J., Wagreich J., Shim J., et al. Perinuclear anti-neutrophil cytoplasmic antibody and refractory pouchitis. A case-control study. Dig Dis Sci 40 9 (1995) 1866-1872
37. Abdelrazeq A.S., Lund J.N., and Leveson S.H. Implications of pouchitis on the functional results following stapled restorative proctocolectomy. Dis Colon Rectum 48 9 (2005) 1700-1707
38. Rath H.C., Herfarth H.H., Ikeda J.S., et al. Normal luminal bacteria, especially bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta(2) microglobulin transgenic rats. J Clin Invest 98 4 (15-8-1996) 945-953
39. Rath H.C., Bender D.E., Holt L.C., et al. Metronidazole attenuates colitis in HLA-B27/β2 microglobulin transgenic rats: a pathogenic role for anaerobic bacteria. Clin Immunol Immunopathol 76 (1996) S45
40. Sutton C.L., Kim J., Yamane A., et al. Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology 119 1 (2000) 23-31
41. Targan S.R., Landers C.J., Yang H., et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 128 7 (2005) 2020-2028